ArticleInfection and drug resistance2020
A Novel
Article in Infection and drug resistance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 10 citations in OpenAlex.
- Genomic Analysis of CTX-M-15-Producing E. coli Colonizing a Rescued Capuchin Monkey.EcoHealth · 2026Article
- Extended-Spectrum β-Lactamase-ProducingInfection and drug resistance · 2025Article
- Tn3-like structures co-harboring of blaBMC veterinary research · 2023Article
- Stability and genetic insights of the co-existence ofFrontiers in public health · 2023Article
- Characterization of microbial community and antibiotic resistome in intra urban water, Wenzhou China.Frontiers in microbiology · 2023Article
- Characterization of NDM-5-producingZoological research · 2022Article
- Spreading Advantages of Coresident PlasmidsMicrobiology spectrum · 2022Article
- Emerging Opportunity and Destiny ofMicrobiology spectrum · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAn ESBL, carbapenemase- and MCR-1-producing
methodsThe strain was fully sequenced by GridION X5 platform of Oxford Nanopore Technology.
resultsThe sequence analysis showed that the extended-spectrum β-lactamases CTX-M-65 and OXA-1, the carbapenemase NDM-5, the MCR-1 were encoded, respectively, by three different resistance plasmids. The pE648CTX-M-65-carrying
conclusionThe three transferable resistance plasmids coexisting in the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.